pISSN 2234-3806eISSN 2234-3814
Fig. 2.
Mutation heatmap of patients with MDS and AML with TP53 mutations.
*These include cytogenetic abnormalities that are neither normal nor complex karyotypes (defined as having three or more abnormalities).
Abbreviations: MDS, myelodysplastic neoplasm; ICC, International Consensus Classification; AML-recurrent, AML with recurrent genetic abnormalities; AML-MRC, AML with myelodysplasia-related changes; AML-NOS, AML, not otherwise specified; MDS-NEB, MDS with non-excess blasts; MDS with EB1, MDS with excess blasts 1; MDS with EB2, MDS with excess blasts 2; NK, normal karyotype; CK, complex karyotype; N, no; Y, yes.
*These include cytogenetic abnormalities that are neither normal nor complex karyotypes (defined as having three or more abnormalities).
Abbreviations: MDS, myelodysplastic neoplasm; ICC, International Consensus Classification; AML-recurrent, AML with recurrent genetic abnormalities; AML-MRC, AML with myelodysplasia-related changes; AML-NOS, AML, not otherwise specified; MDS-NEB, MDS with non-excess blasts; MDS with EB1, MDS with excess blasts 1; MDS with EB2, MDS with excess blasts 2; NK, normal karyotype; CK, complex karyotype; N, no; Y, yes.
Ann Lab Med 2025;45:160~169 https://doi.org/10.3343/alm.2024.0351
© Ann Lab Med